About [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone
[1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone (PubChem CID 155922333) has the molecular formula C26H27F3N10O2
and a molecular weight of 568.56 g/mol. Its IUPAC name is [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone.
Molecular Properties
| Compound Name | [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone |
| PubChem CID | 155922333 |
| Molecular Formula | C26H27F3N10O2 |
| Molecular Weight | 568.56 g/mol |
| Exact Mass | 568.23 |
| IUPAC Name | [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone |
| SMILES | O=C(c1cnn(C2COC2)c1)N1CCN(c2ccnc(-c3cnc4ccc(C(F)(F)F)cn34)n2)CC1C1CNNC1 |
| InChI | InChI=1S/C26H27F3N10O2/c27-26(28,29)18-1-2-22-31-10-20(38(22)12-18)24-30-4-3-23(35-24)36-5-6-37(21(13-36)16-7-32-33-8-16)25(40)17-9-34-39(11-17)19-14-41-15-19/h1-4,9-12,16,19,21,32-33H,5-8,13-15H2 |
| InChIKey | QMAHHQRNZDEBEH-UHFFFAOYSA-N |
| XLogP | 1.63 |
| TPSA | 117.74 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 568.56 |
| LogP ≤ 5 | 1.63 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Analyze [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone?
The IUPAC name of [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone (CID 155922333) is [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone.
What is the SMILES notation for [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone?
The canonical SMILES for [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone is O=C(c1cnn(C2COC2)c1)N1CCN(c2ccnc(-c3cnc4ccc(C(F)(F)F)cn34)n2)CC1C1CNNC1.
What is the InChIKey of [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone?
The InChIKey is QMAHHQRNZDEBEH-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H27F3N10O2/c27-26(28,29)18-1-2-22-31-10-20(38(22)12-18)24-30-4-3-23(35-24)36-5-6-37(21(13-36)16-7-32-33-8-16)25(40)17-9-34-39(11-17)19-14-41-15-19/h1-4,9-12,16,19,21,32-33H,5-8,13-15H2.
What are the key properties of [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone?
[1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone has a molecular weight of 568.56 g/mol, XLogP of 1.63, 5 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [1-(oxetan-3-yl)pyrazol-4-yl]-[2-pyrazolidin-4-yl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]piperazin-1-yl]methanone is sourced from PubChem (CID 155922333), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).